Analysis of Risk Factors for Loculated Pleural Effusion in Patients with Tuberculous Pleural Effusion at dr. Zainoel Abidin Hospital
DOI:
https://doi.org/10.36497/jri.v45i4.822Keywords:
age, diabetes mellitus, kidney failure, loculated pleural effusion, tuberculousAbstract
Background: Loculated pleural effusion is an effusion that has a lenticular configuration with smooth borders and is relatively homogeneous and can cause atelectasis in the surrounding lung tissue and is a result of excessive inflammation. Tuberculous pleural effusion is characterized by chronic accumulation of fluid and inflammatory cells in the pleural cavity. If not treated appropriately, a loculated pleural effusion can be life-threatening. This study aims to assess risk factors for loculated pleural effusion in TB pleural effusion patients.
Method: This is an observational, analytical research with a cross-sectional design. The research sample was taken based on a consecutive sampling technique from TB pleural effusion patients treated at dr. Zainoel Abidin Hospital, Banda Aceh, from January 2024 to April 2024.
Results: This study shows a relationship between age, kidney failure and diabetes mellitus on the incidence of loculated pleural effusion in TB pleural effusion patients (P<0.05). Age ≥46 years old has a 12.57 times risk, kidney failure 5.50 times and DM 14.5 times against the incidence of loculated pleural effusion. Gender, anemia, human immunodeficiency virus (HIV), pleural fluid analysis results and positive culture did not correlate with loculated pleural effusion (P>0.05).
Conclusion: Age, kidney failure and diabetes mellitus are risk factors for loculated pleural effusion. The increase in age-related risk is associated with chronic inflammation, called inflammaging. Increasing age is also associated with changes in the composition and function of lung cells, making the clearance of pathogens difficult. Intense inflammation and difficulty in clearing pathogens also contribute to the association of kidney failure and diabetes mellitus with loculated pleural effusion.
Downloads
References
1. Raviglione M, Sulis G. Tuberculosis 2015: Burden, challenges and strategy for control and elimination. Infect Dis Rep. 2016;8(2):6570.
2. Dinas Kesehatan Aceh. Laporan kinerja Dinas Kesehatan Aceh tahun 2023. Banda Aceh; 2023.
3. Lo Cascio CM, Kaul V, Dhooria S, Agrawal A, Chaddha U. Diagnosis of tuberculous pleural effusions: A review. Respir Med. 2021;188:106607.
4. Zhai K, Lu Y, Shi H zhong. Tuberculous pleural effusion. J Thorac Dis. 2016;8(7):E486–94.
5. Shaw JA, Diacon AH, Koegelenberg CFN. Tuberculous pleural effusion. Respirology. 2019;24(10):962–71.
6. Thomas R, Jenkins S, Eastwood PR. Physiology of breathlessness associated with pleural effusions. 2015;21(4):338–45.
7. Mitrouska I, Klimathianaki M, Mitrouska I, Klimathianaki M. Effects of pleural effusion on respiratory function. Can Respir J. 2004;11(7):499–503.
8. Tucker TA, Idell S. Update on novel targeted therapy for pleural organization and fibrosis. Int J Mol Sci. 2022;23(3):1587.
9. Esmadi M, Lone N, Ahmad DS, Onofrio J, Brush RG. Multiloculated pleural effusion detected by ultrasound only in a critically-ill patient. American Journal of Case Reports. 2013;14:63–6.
10. Kennedy F. Beyond “prevention is better than cure”: Understanding prevention and early intervention as an approach to public policy. Policy Design and Practice. 2020;3(4):351–69.
11. Wang JL, Zhou M, Zhang YA, Wang MS. Loculations and associated risk factors of childhood pleural tuberculosis. Front Pediatr. 2021;9:781042.
12. Ampow AT, Timban JFJ, Rondo AGEY. Gambaran foto toraks pasien tuberkulosis paru dengan efusi pleura di RSUP Prof. Dr. R. D. Kandou periode Januari – Juni 2022. Medical Scope Journal. 2023;5(1):57–63.
13. Ko Y, Kim C, Chang B, Lee SY, Park SY, Mo EK, et al. Loculated tuberculous pleural effusion: Easily identifiable and clinically useful predictor of positive mycobacterial culture from pleural fluid. Tuberc Respir Dis (Seoul). 2017;80(1):35–44.
14. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–38.
15. Orme IM, Griffin JP, Roberts AD, Ernst DN. Evidence for a defective accumulation of protective T cells in old mice infected with mycobacterium tuberculosis. Cell Immunol. 1993;147(1):222–9.
16. Cho SH, Lee H, Kwon H, Shin DW, Joh HK, Han K, et al. Association of underweight status with the risk of tuberculosis: A nationwide population-based cohort study. Sci Rep. 2022;12:16207.
17. Ganmaa D, Uyanga B, Zhou X, Gantsetseg G, Delgerekh B, Enkhmaa D, et al. Vitamin D supplements for prevention of tuberculosis infection and disease. New England Journal of Medicine. 2020;383(4):359–68.
18. Ashenafi S, Bekele A, Aseffa G, Amogne W, Kassa E, Aderaye G, et al. Anemia is a strong predictor of aasting, disease severity, and progression, in clinical tuberculosis (TB). Nutrients. 2022;14(16):3318.
19. Hof A, Geißen S, Singgih K, Mollenhauer M, Winkels H, Benzing T, et al. Myeloid leukocytes’ diverse effects on cardiovascular and systemic inflammation in chronic kidney disease. Basic Res Cardiol. 2022;117(1):38.
20. Paul K, Kretzschmar D, Yilmaz A, Bärthlein B, Titze S, Wolf G, et al. Circulating dendritic cell precursors in chronic kidney disease: A cross-sectional study. BMC Nephrol. 2013;14(1):274.
21. Heller T, Mtemang’ombe EA, Huson MAM, Heuvelings CC, Bélard S, Janssen S, et al. Ultrasound for patients in a high HIV/tuberculosis prevalence setting: A needs assessment and review of focused applications for Sub-Saharan Africa. International Journal of Infectious Diseases. 2017;56:229–36.
22. Muchtar NH, Herman D, Yulistini Y. Gambaran faktor risiko timbulnya tuberkulosis paru pada pasien yang berkunjung ke unit DOTS RSUP Dr. M. Djamil Padang tahun 2015. Jurnal Kesehatan Andalas. 2018;7(1):80–7.
23. Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2019;16(5):442–9.
24. Andrade C. Sample size and its importance in research. Indian J Psychol Med. 2020;42(1):102–3.
25. DeRiemer K, Kawamura LM, Hopewell PC, Daley CL. Quantitative impact of human immunodeficiency virus infection on tuberculosis dynamics. Am J Respir Crit Care Med. 2007;176(9):936–44.
26. Mohamad WMW, Ab Rahman WSW, Al-Salih SAA, Hussin CMC. Immunological and haematological changes in HIV infection. In: Trends in Basic and Therapeutic Options in HIV Infection - Towards a Functional Cure. InTech; 2015.
27. Abuga KM, Nairz M, MacLennan CA, Atkinson SH. Severe anaemia, iron deficiency, and susceptibility to invasive bacterial infections. Wellcome Open Res. 2023;8:48.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muhammad Purqan, Yunita Arliny, Herry Priyanto, Dewi Behtri Yanifitri, Budi Yanti
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
